Print ResearchMayo Clinic researchers are studying the use of COVID-19 convalescent plasma therapy. They are focusing on people in the hospital for COVID-19 and people with severely weakened immune systems who have COVID-19. The goal is to determine if COVID-19 convalescent plasma therapy improves the chance of recovery for people with the most severe disease. They also plan to test whether COVID-19 convalescent plasma can help keep people who are moderately sick from getting sicker. And they will test COVID-19 convalescent plasma to see if it helps prevent the need for hospitalization. Find out more about researchCOVID-19 at Mayo Clinic. PublicationsSee a list of publications about convalescent plasma therapy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles Edit search filters close Narrow your search By location Arizona Florida Minnesota View all View all physicians • Minnesota Joyner, Michael J. M.D. Minnesota Nicholson, Nick T. M.D., Pharm.D. Minnesota Winters, Jeffrey L. M.D. Minnesota Wood, Douglas L. M.D. Minnesota Wright, R. Scott M.D. Minnesota By Mayo Clinic Staff Convalescent plasma therapy care at Mayo Clinic AboutCare at Mayo Clinic July 21, 2023 Print Show references Investigational COVID-19 convalescent plasma. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma. Accessed May 2, 2023. Hoffman R, et al. Principles of plasma and plasma derivatives. In: Hematology. 8th edition. Elsevier. 2023. https://www.clinicalkey.com. Accessed May 2, 2023. Marano G, et al. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016; doi:10.2450/2015.0131-15. Emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed May 2, 2023. AskMayoExpert. Convalescent Plasma. Mayo Clinic; 2023. COVID-19 convalescent plasma. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/covid-19-convalescent-plasma/. Accessed May 2. 2023. Rajendran K, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Journal of Medical Virology. 2020; doi:10.1002/jmv.25961. Senefeld JW, et al. COVID-19 Convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. Journal of the American Medical Association: Network Open. 2023; doi:10.1001/jamanetworkopen.2022.50647. COVID-19 treatments and medications. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html. Accessed May 2, 2023. Kim AR. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. https://www.uptodate.com/contents/search. Accessed May 2, 2023. Infectious disease, HLA and ABO donor qualification testing. American Red Cross. https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html. Accessed May 3, 2023. Tulledge-Scheitel, S (expert opinion). Mayo Clinic. May 5, 2023. Related Coronavirus disease 2019 (COVID-19) Products & Services A Book: Endemic - A Post-Pandemic Playbook Convalescent plasma therapyAboutDoctors&DepartmentsCare atMayoClinic PRC-20486437 Patient Care & Health Information Tests & Procedures Convalescent plasma therapy